When one and one make three: HLA and EBV infection in MS.
Marrie
Ruth Ann
RA
D000906:Antibodies / Q000032:analysis / Q000097:blood / Q000276:immunology; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D015984:Causality; D015897:Comorbidity; D020031:Epstein-Barr Virus Infections / Q000097:blood / Q000453:epidemiology* / Q000276:immunology; D005260:Female; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D005838:Genotype; D006684:HLA-DR Antigens / Q000032:analysis / Q000097:blood* / Q000276:immunology; D059810:HLA-DR Serological Subtypes; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D009103:Multiple Sclerosis / Q000097:blood / Q000453:epidemiology* / Q000276:immunology; D011237:Predictive Value of Tests; D012307:Risk Factors; D018401:Sample Size
D000906:Antibodies; D015415:Biomarkers; D006684:HLA-DR Antigens; D059810:HLA-DR Serological Subtypes; C106559:HLA-DR15 antigen